SCHEMBL21973441

SCHEMBL21973441

C=C/C=C(\C=C/N)c1ncno1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20018104 0.65 SMN1; SMN2 (0.36)
SCHEMBL10268848 0.62
SCHEMBL11933762 0.61 MASP2 (0.34)
SCHEMBL17149437 0.60 ALDH1A1 (0.39)
SCHEMBL13896674 0.59
SCHEMBL12344977 0.58 ALDH1A1 (0.41)
SCHEMBL15762046 0.58 MAOA (0.37)
SCHEMBL17149441 0.57 SMN1; SMN2 (0.42)
SCHEMBL15026717 0.57 FAAH (0.35)
SCHEMBL17624570 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3288936-B1 BENZIMIDAZOLONE AND BENZOTHIAZOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-05-06 EP disclosed